Research programme: small molecule enzyme inhibitors - OncoTherapy Science

Drug Profile

Research programme: small molecule enzyme inhibitors - OncoTherapy Science

Alternative Names: Methyltransferase SUV39H2 inhibitors - OncoTherapy Science; OTS 193320; OTS-514; OTS-964; T-LAK cell-originated protein kinase inhibitors - OncoTherapy Science; TOPK inhibitors - OncoTherapy Science

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator OncoTherapy Science
  • Developer OncoTherapy Science; University of Chicago
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Methyltransferase inhibitors; PDZ-binding kinase inhibitors; Protein kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Acute myeloid leukaemia; Breast cancer; Cancer

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Japan
  • 01 Apr 2017 Preclinical trials in Breast cancer in Japan, USA before April 2017 (IV)
  • 01 Apr 2017 Pharmacodynamics data from a preclinical study trial in Breast cancer presented at the 108th Annual Meeting of the American Association for Cancer Research (AACR-2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top